Medicare Part D coverage · dextroamphetamine sulfate · RxCUI 884535
dextroamphetamine sulfate 5 MG Extended Release Oral Capsule
Per the CMS 2026 Part D formulary file, dextroamphetamine sulfate 5 MG Extended Release Oral Capsule is covered by 2,530 Medicare Part D plans (50.1% of enrollable products), averaging Tier 3.1, with prior authorization required on 0.9% of covering formularies.
- 50.1%
- Plan coverage
- 2,530
- Plans covering
- T3.1
- Avg tier
- 0.9%
- Prior auth required
What the CMS Formulary Data Shows for dextroamphetamine sulfate 5 MG Extended Release Oral Capsule
Per the CMS 2026 Part D formulary file, dextroamphetamine sulfate 5 MG Extended Release Oral Capsule (RxNorm concept RXCUI 884535, generic name dextroamphetamine sulfate) appears on 109 distinct formulary files spanning 2,530 Medicare Part D plan offerings - 50.1% of enrollable Part D products, mid-range placement; shopping across contracts changes access. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 3.1.
Real-world access to dextroamphetamine sulfate 5 MG Extended Release Oral Capsule depends on utilization management as much as tier placement: 0.9% of covering formularies require prior authorization. 0% require step therapy. 79.8% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 9,950 Part D beneficiaries filled dextroamphetamine sulfate 5 MG Extended Release Oral Capsule in 2023, with total plan-and-beneficiary spending of $5,176,356 and an average per-beneficiary annual cost of $520.24. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry dextroamphetamine sulfate 5 MG Extended Release Oral Capsule today.
Coverage Details
- Formularies covering
- 109
- Plans covering
- 2,530
- Coverage rate
- 50.1%
- Tier range
- Tier 1 – Tier 4
- Average tier
- Tier 3, Preferred Brand
Restrictions
- Prior authorization required
- 0.9% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 79.8% of formularies
2023 Medicare Spending
- Beneficiaries
- 9,950
- Total spending
- $5,176,356
- Avg per beneficiary
- $520.24
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering dextroamphetamine sulfate 5 MG Extended Release Oral Capsule
100 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| CareAdvantage (HMO D-SNP) | SAN Mateo Health Commission | T1 | No | $0 | CA |
| Gold Coast Health Plan Total Care Advantage (HMO D-SNP) | Ventura County Medi-Cal Managed Care Commission | T1 | No | $0 | CA |
| Blue Cross Medicare Advantage Dual Care Plus (HMO D-SNP) | Health Care Service Corporation | T1 | No | $0 | NM |
| Blue Cross MA Dual Care Plus Preferred (PPO D-SNP) | Health Care Service Corporation | T1 | No | $0 | NM |
| SecureBlue (HMO D-SNP) | HMO Minnesota | T1 | No | $0 | MN |
| NaviCare (HMO D-SNP) | Fallon Community Health Plan | T1 | No | $0 | MA |
| Hamaspik Medicare Choice (HMO D-SNP) | Hamaspik, Inc. | T1 | No | $0 | NY |
| SeniorCare Complete (HMO D-SNP) | South Country Health Alliance | T1 | No | $0 | MN |
| AbilityCare (HMO D-SNP) | South Country Health Alliance | T1 | No | $0 | MN |
| Alameda Alliance Wellness (HMO D-SNP) | Alameda Alliance FOR Health | T1 | No | $0 | CA |
| PHP (HMO C-snp) | Aids Healthcare Foundation | T1 | No | $0 | CA |
| VNS Health Total (HMO D-SNP) | VNS Choice | T1 | No | $0 | NY |
| Community Care's Partnership Program (HMO D-SNP) | Community Care Health Plan, Inc. | T1 | No | $0 | WI |
| Platino Blindao (HMO D-SNP) | Triple S Advantage, Inc. | T1 | No | $0 | PR |
| Platino Enlace (HMO D-SNP) | Triple S Advantage, Inc. | T1 | No | $0 | PR |
| Platino Advance (HMO D-snp) | Triple S Advantage, Inc. | T1 | No | $0 | PR |
| Platino Plus (HMO D-snp) | Triple S Advantage, Inc. | T1 | No | $0 | PR |
| CalOptima Health OneCare Complete (HMO D-SNP) | Orange County Health Authority | T1 | Yes | $0 | CA |
| Highmark Wholecare Medicare Assured Diamond (HMO D-SNP) | Gateway Health Plan, Inc. | T1 | No | $0 | PA |
| Highmark Wholecare Medicare Assured Diamond (HMO D-SNP) | Gateway Health Plan, Inc. | T1 | No | $0 | PA |
Show the next 30 plans
| Highmark Health Options Duals (HMO D-SNP) | Highmark Health Options West Virginia Inc. | T1 | No | $0 | WV |
| Highmark Health Options Duals (HMO D-SNP) | Highmark Bcbsd, Inc. | T1 | No | $0 | DE |
| Tufts Health One Care (HMO D-SNP) | Tufts Health Public Plans, Inc. | T1 | No | $0 | MA |
| Tufts Health One Care CW (HMO D-SNP) | Tufts Health Public Plans, Inc. | T1 | No | $0 | MA |
| Tufts Health Plan Senior Care Options (HMO D-SNP) | Tufts Associated Health Maintenance Organization | T1 | No | $0 | MA |
| Tufts Health Plan Senior Care Options CW (HMO D-SNP) | Tufts Associated Health Maintenance Organization | T1 | No | $0 | MA |
| Blue Cross Medicare Advantage Dual Care Plus (HMO D-SNP) | Hcsc Insurance Services Company | T1 | No | $4.80 | TX |
| Gold Dialysis & Kidney Complete (HMO-POS C-SNP) | Gold Kidney OF Florida Inc | T1 | No | $4.80 | FL |
| Blue Cross Medicare Advantage Dual Care Plus (HMO D-SNP) | GHS Insurance Company | T1 | No | $5.00 | OK |
| Highmark Wholecare Medicare Assured Ruby (HMO D-SNP) | Gateway Health Plan, Inc. | T1 | No | $13.10 | PA |
| Gold Dialysis & Kidney Complete (HMO-POS C-SNP) | Gold Kidney OF Arizona | T1 | No | $17.00 | AZ |
| Highmark Wholecare Medicare Assured Ruby (HMO D-SNP) | Gateway Health Plan, Inc. | T1 | No | $17.60 | PA |
| Highmark Health Options Duals Select (HMO D-SNP) | Highmark Bcbsd, Inc. | T1 | No | $31.20 | DE |
| Hamaspik Medicare Select (HMO D-SNP) | Hamaspik, Inc. | T1 | No | $34.50 | NY |
| VNS Health EasyCare Plus (HMO D-SNP) | VNS Choice | T1 | No | $51.60 | NY |
| Freedom VIP Care (HMO C-SNP) | Freedom Health, Inc. | T2 | No | $0 | FL |
| Freedom VIP Savings (HMO C-SNP) | Freedom Health, Inc. | T2 | No | $0 | FL |
| Freedom VIP Savings (HMO C-SNP) | Freedom Health, Inc. | T2 | No | $0 | FL |
| Freedom VIP Rewards (HMO C-SNP) | Freedom Health, Inc. | T2 | No | $0 | FL |
| Freedom VIP Rewards (HMO C-SNP) | Freedom Health, Inc. | T2 | No | $0 | FL |
| Optimum Diamond Rewards (HMO C-SNP) | Optimum Healthcare, Inc. | T2 | No | $0 | FL |
| Optimum Diamond Savings (HMO C-SNP) | Optimum Healthcare, Inc. | T2 | No | $0 | FL |
| Optimum Diamond Rewards (HMO C-SNP) | Optimum Healthcare, Inc. | T2 | No | $0 | FL |
| Optimum Diamond (HMO C-SNP) | Optimum Healthcare, Inc. | T2 | No | $0 | FL |
| Freedom Medi-Medi Partial (HMO D-SNP) | Freedom Health, Inc. | T2 | No | $0 | FL |
| Freedom Medi-Medi Full (HMO D-SNP) | Freedom Health, Inc. | T2 | No | $0 | FL |
| Optimum Emerald Partial (HMO D-SNP) | Optimum Healthcare, Inc. | T2 | No | $0 | FL |
| Optimum Emerald Full (HMO D-SNP) | Optimum Healthcare, Inc. | T2 | No | $0 | FL |
| Freedom Medicare Plan Rx (HMO) | Freedom Health, Inc. | T2 | No | $0 | FL |
| Freedom Medicare Plan Rx (HMO) | Freedom Health, Inc. | T2 | No | $0 | FL |
Showing top 50 of 100 plans.
Frequently Asked Questions
Is dextroamphetamine sulfate 5 MG Extended Release Oral Capsule covered by Medicare Part D?
Yes, dextroamphetamine sulfate 5 MG Extended Release Oral Capsule is covered by 2,530 Medicare Part D plans (50.1% of all Part D formularies).
What tier is dextroamphetamine sulfate 5 MG Extended Release Oral Capsule on Medicare Part D plans?
dextroamphetamine sulfate 5 MG Extended Release Oral Capsule averages Tier 3.1 across Part D plans, ranging from Tier 1 to Tier 4.
Does dextroamphetamine sulfate 5 MG Extended Release Oral Capsule require prior authorization?
0.9% of Part D formularies require prior authorization for dextroamphetamine sulfate 5 MG Extended Release Oral Capsule. Step therapy: 0%. Quantity limits: 79.8%.
How much does Medicare spend on dextroamphetamine sulfate 5 MG Extended Release Oral Capsule?
In 2023, total Medicare Part D spending on dextroamphetamine sulfate 5 MG Extended Release Oral Capsule was $5,176,356, covering 9,950 beneficiaries. The average spend per beneficiary was $520.24.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
- aripiprazole 15 MG Disintegrating Oral Tablet T3.1
- isotretinoin 30 MG Oral Capsule [Amnesteem] T3.1
- Pulmonary Hypertension tadalafil 20 MG Oral Tablet [Alyq] T3.1
- 1250 MG testosterone 0.0162 MG/MG Topical Gel T3.1
- 24 HR pramipexole dihydrochloride 1.5 MG Extended Release Oral Tablet T3.1
- clindamycin 10 MG/ML Topical Foam T3.1
Similar prior-authorization rate
- tramadol hydrochloride 50 MG Oral Tablet 0.9% PA
- cycloserine 250 MG Oral Capsule 0.9% PA
- acetaminophen 300 MG / codeine phosphate 60 MG Oral Tablet 0.9% PA
- acetaminophen 300 MG / codeine phosphate 15 MG Oral Tablet 0.9% PA
- acetaminophen 24 MG/ML / codeine phosphate 2.4 MG/ML Oral Solution 0.9% PA
- oxycodone hydrochloride 5 MG Oral Tablet 0.9% PA